These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8693263)

  • 1. [Vaccines].
    Bonard EC
    Rev Med Suisse Romande; 1996 Apr; 116(4):305-7. PubMed ID: 8693263
    [No Abstract]   [Full Text] [Related]  

  • 2. Time for a worldwide shift from oral polio vaccine to inactivated polio vaccine.
    Shahzad A
    Clin Infect Dis; 2009 Oct; 49(8):1287-8. PubMed ID: 19780666
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety aspects of oral poliovirus vaccine campaigns.
    Hovi T
    Dev Biol Stand; 1995; 84():137-44. PubMed ID: 7796946
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on new attenuated strains of type III live poliomyelitis vaccine. II. Field trials of Zhong III2 virus.
    Chin Med J (Engl); 1980 Sep; 93(9):591-8. PubMed ID: 6253237
    [No Abstract]   [Full Text] [Related]  

  • 5. Infectious diseases. Polio outbreak raises questions about vaccine.
    Greensfelder L
    Science; 2000 Dec; 290(5498):1867-9. PubMed ID: 11187033
    [No Abstract]   [Full Text] [Related]  

  • 6. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
    Cáceres VM; Sutter RW
    Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
    Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
    Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virology. Poliomyelitis eradication--a dangerous endgame.
    Nathanson N; Fine P
    Science; 2002 Apr; 296(5566):269-70. PubMed ID: 11951020
    [No Abstract]   [Full Text] [Related]  

  • 9. When can we stop using oral poliovirus vaccine?
    Hull HF; Minor PD
    J Infect Dis; 2005 Dec; 192(12):2033-5. PubMed ID: 16288363
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular consistency monitoring of oral poliovirus vaccine and other live viral vaccines.
    Chumakov KM
    Dev Biol Stand; 1999; 100():67-74. PubMed ID: 10616177
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with vaccines produced in the human diploid cell line WI-38.
    Andzaparidze OG
    Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
    [No Abstract]   [Full Text] [Related]  

  • 12. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paralytic poliomyelitis--United States, 1980-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
    Fescharek R; Arras-Reiter C; Arens ER; Quast U; Maass G
    Wien Med Wochenschr; 1997; 147(19-20):456-61. PubMed ID: 9471843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polio vaccines and the cessation of vaccination.
    Minor PD
    Expert Rev Vaccines; 2003 Feb; 2(1):99-104. PubMed ID: 12901601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems with the oral polio vaccine.
    Bhasin VK
    Nat Med; 2008 Jan; 14(1):9. PubMed ID: 18180708
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
    Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
    J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring vaccines for human oncogenicity.
    Miller RW
    Natl Cancer Inst Monogr; 1968 Dec; 29():453-5. PubMed ID: 4305436
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.
    Tebbens RJ; Pallansch MA; Kew OM; Cáceres VM; Jafari H; Cochi SL; Sutter RW; Aylward RB; Thompson KM
    Risk Anal; 2006 Dec; 26(6):1471-505. PubMed ID: 17184393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.